Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 13:2023:7665515.
doi: 10.1155/2023/7665515. eCollection 2023.

Royal Jelly Increases Hematopoietic Stem Cells in Peripheral Blood: A Double-Blind, Placebo-Controlled, Randomized Trial in Healthy Subjects

Hideto Okamoto  1 , Akio Ohkuma  2 , Mitsuhiko Kawaguchi  3 , Norihiro Shigematsu  1 , Nobuaki Okumura  1
Affiliations

Royal Jelly Increases Hematopoietic Stem Cells in Peripheral Blood: A Double-Blind, Placebo-Controlled, Randomized Trial in Healthy Subjects

Hideto Okamoto et al. Evid Based Complement Alternat Med. .

Abstract

Objectives: Royal jelly (RJ), produced by honeybees, influences stem cell functions, such as pluripotency maintenance of mouse embryonic stem cells and prevention of aging-related muscle stem cell functional deterioration. Thus, we hypothesized that RJ administration has various health-promoting effects based on stem cells. However, its effects are unknown in humans. In this study, we have attempted for the first time to clarify whether the administration of RJ in humans affects stem cells.

Materials and methods: This randomized, double-blind, placebo-controlled study was performed on healthy subjects (n = 90) who received protease-treated RJ at a dose of 1200 mg/day or placebo daily for four weeks. Also, the participants with a low number of hematopoietic stem cells (HSCs) in peripheral blood were preferentially selected. HSC counts, endothelial progenitor cell (EPC) counts, blood cell counts in peripheral blood, cytokines in serum, and physical conditions were evaluated. Results and Conclusion. Eligible data from 86 subjects (placebo: 42, RJ: 44) who completed the study were analyzed. There were no significant differences between the two groups regarding the changes in peripheral HSC count (p=0.103), while diastolic blood pressure showed a significant improvement in the RJ group compared to that in the placebo group (p=0.032). The subgroup analysis excluded 14 subjects who complained of cold symptoms at baseline or within five days of the four-week study. The changes in the HSC populations were significantly higher in the RJ group than those in the placebo group (p=0.042). No adverse effects were observed in any of the groups. These results suggest that RJ administration affected the peripheral HSC count and may influence stem cell functions. Further research is needed to reveal the various health-promoting benefits of RJ based on stem cells.

PubMed Disclaimer

Conflict of interest statement

Hideto Okamoto, Norihiro Shigematsu, and Nobuaki Okumura are employees of Yamada Bee Company, Inc. The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Flow diagram of the study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Fuentes E., Fuentes M., Alarcón M., Palomo I. Immune system dysfunction in the elderly. Anais da Academia Brasileira de Ciências . 2017;89(1):285–299. doi: 10.1590/0001-3765201720160487. - DOI - PubMed
    1. Lanier J. B., Park J. J., Callahan R. C. Anemia in older adults. American Family Physician . 2018;98(7):437–442. - PubMed
    1. Partridge L., Deelen J., Slagboom P. E. Facing up to the global challenges of ageing. Nature . 2018;561(7721):45–56. doi: 10.1038/s41586-018-0457-8. - DOI - PubMed
    1. López-Otín C., Blasco M. A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell . 2013;153(6):1194–1217. doi: 10.1016/j.cell.2013.05.039. - DOI - PMC - PubMed
    1. Takizawa H., Fritsch K., Kovtonyuk L. V., et al. Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness. Cell Stem Cell . 2017;21(2):225–240.e5. doi: 10.1016/j.stem.2017.06.013. - DOI - PubMed

LinkOut - more resources